TSXV - Delayed Quote ? CAD BioRem Inc. (BRM.V) Follow Compare 2.6100 +0.0300 (+1.16%) At close: October 25 at 3:42 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver VANCOUVER, BC / ACCESSWIRE / September 24, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 25-26, 2024, where 50 MicroCap public and private companies will be presenting at the Fairmont Waterfront ... ACCESSWIRE ? last month SSLCF GHIFF NWVCF BioRem Second Quarter 2024 Earnings: EPS: CA$0.021 (vs CA$0.006 loss in 2Q 2023) BioRem ( CVE:BRM ) Second Quarter 2024 Results Key Financial Results Revenue: CA$7.30m (up 71% from 2Q 2023). Net... Simply Wall St. ? last month BIRMF Biorem Reports Second Quarter Results with 77% Increase in Year over Year Revenue and Record Order Backlog BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2024. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com). CNW Group ? 2 months ago BIRMF BioRem Inc.'s (CVE:BRM) Stock Is Going Strong: Have Financials A Role To Play? Most readers would already be aware that BioRem's (CVE:BRM) stock increased significantly by 39% over the past three... Simply Wall St. ? 3 months ago BIRMF Biorem Announces Stock Option Grant Biorem Inc. (TSXV:BRM)("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company. The options are exercisable at a price of $1.96 per share for a period of ten years from the date of grant. CNW Group ? 4 months ago BIRMF BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com). CNW Group ? 4 months ago BIRMF Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las ... ACCESSWIRE ? 5 months ago MAMA ELUT BIOYF Biorem Reports 2023 Financial Results including $0.14 earnings per share BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com). CNW Group ? 6 months ago BIRMF Biorem Reports Third Quarter Results, Record Order Backlog and Quarterly EPS of $0.03 BIOREM Inc. (TSXV: BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2023. BIOREM's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com). CNW Group ? 10 months ago BIRMF Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return BRM.V S&P/TSX Composite index YTD +161.00% +16.72% 1-Year +207.06% +28.85% 3-Year +203.49% +15.31%
